CHR. OLESEN PHARMACEUTICALS A/S: Financial statements 2014
CVR: 32090168
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
CHR. OLESEN PHARMACEUTICALS A/S (CVR 32090168) has filed annual accounts for 2014. In 2014, the company reported a gross profit of EUR 125,269 and a net result of EUR 3,124,775 compared with EUR -1,305,001 the year before. That is a decrease of 82.9% compared with the year before. Equity in the 2014 report amounted to EUR -212,450. The company had 1 employee in the financial year.
- Gross Profit
- EUR 125,269
- Profit/Loss
- EUR 3,124,775
- Equity
- EUR -212,450
- Total Assets
- EUR 4,713,082
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 125K EUR | 3.1M EUR | -212K EUR | 1 |
| 2013 | - | 734K EUR | -1.3M EUR | -3.3M EUR | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 30, 2014, Hans-Hermann Will has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Mads Christian Olesen has joined the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Allan Ardensø has left the board of directors of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Mads Christian Olesen is registered as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
As of May 23, 2014, Svend Aage Johansen has stepped down as adm. dir. of CHR. OLESEN PHARMACEUTICALS A/S.
CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2013. Gross profit came to DKK 733,894, and the net result was DKK -1,305,001.
About CHR. OLESEN PHARMACEUTICALS A/S
CHR. OLESEN PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen. The board consists of Tobias Facklam (chair), Christian Dam Olesen and Fabian von Volkmann. The company is owned by CHR. OLESEN A/S and SVVF UG & Co. KG. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR 1,210,782 and a net result of EUR 237,447 compared with EUR 70,556 the year before. Equity in the 2025 report amounted to EUR 1,744,707.
